Spots Global Cancer Trial Database for acute lymphoblastic leukemia
Every month we try and update this database with for acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses | NCT00192673 | Acute Lymphobla... | PEG-asparaginas... | 1 Year - 14 Years | Nordic Society for Pediatric Hematology and Oncology | |
| Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL | NCT05071482 | Acute Leukemia | Flumatinib Imatinib | 18 Years - 65 Years | Institute of Hematology & Blood Diseases Hospital, China | |
| Repeat Dose Safety Study for Compound to Treat Hematologic Cancer | NCT00881946 | Hematologic Mal... | GSK21110183 | 18 Years - | Accenture | |
| Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia | NCT03803670 | Acute Lymphobla... | evaluation of c... | - | University of Rome Tor Vergata | |
| Repeat Dose Safety Study for Compound to Treat Hematologic Cancer | NCT00881946 | Hematologic Mal... | GSK21110183 | 18 Years - | Accenture | |
| N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors | NCT01913093 | Childhood Leuke... | 8 Years - 20 Years | The Hospital for Sick Children | ||
| Aerobic and Strengthening Exercise for Acute Leukemia | NCT00766311 | Acute Lymphobla... | Gross Motor Fun... Knee extension ... Hand grip stren... Flexibility Ankle range of ... Aerobic capacit... Body compositio... | 5 Years - 10 Years | St. Jude Children's Research Hospital | |
| Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment | NCT02099266 | Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Hodgkins Lympho... Non-Hodgkins Ly... | Administration ... | 17 Years - 70 Years | University of Kansas Medical Center | |
| Low GI Diet in Children and Adolescents With ALL | NCT03157323 | Acute Lymphobla... Obesity, Pediat... | Low Glycemic In... | 5 Years - 21 Years | Columbia University | |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer | NCT00723099 | Acute Lymphobla... Acute Myeloid L... Aggressive Non-... Chronic Myeloge... Chronic Phase C... Indolent Non-Ho... Lymphoma Mixed Phenotype... Myelodysplastic... Myeloproliferat... Recurrent Chron... Recurrent Folli... Recurrent Lymph... Recurrent Mantl... Recurrent Margi... Recurrent Plasm... Recurrent Small... Recurrent T-Cel... Refractory Chro... Refractory Chro... Refractory Foll... Refractory Hodg... Refractory Lymp... Refractory Mant... Refractory Smal... T-Cell Non-Hodg... | Allogeneic Hema... Cyclophosphamid... Cyclosporine Fludarabine Pho... Laboratory Biom... Mycophenolate M... Total-Body Irra... Umbilical Cord ... | - 69 Years | Fred Hutchinson Cancer Center | |
| The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China | NCT04228393 | Acute Lymphobla... | 6-mercaptopurin... Standard treatm... Individualized ... | 1 Year - 18 Years | Shandong University | |
| Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies | NCT02639559 | Acute Myelogeno... Acute Lymphobla... Chronic Myeloge... Non-Hodgkin's L... Non-Hodgkin Lym... Hodgkin Disease Hodgkins Diseas... Hodgkin's Disea... Multiple Myelom... Myelodysplastic... Myeloproliferat... | BL-8040 Leukapheresis Hematopoietic c... | 18 Years - 75 Years | Washington University School of Medicine | |
| Pharmacogenomics of Asparaginase Induced Hepatotoxicity | NCT03568266 | Acute Lymphobla... | Biospecimen Col... | 18 Years - | University of Southern California | |
| A Study in Adults With Untreated Acute Lymphoblastic Leukemia | NCT00136435 | Acute Lymphobla... | prednisone doxorubicin vincristine methotrexate asparaginase dexamethasone cranial radiati... leucovorin cytarabine hydrocortisone 6-mercaptopurin... e. coli L-aspar... | 18 Years - 50 Years | Dana-Farber Cancer Institute | |
| Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia | NCT01677949 | Acute Myeloid L... Acute Lymphobla... | Clofarabine Etoposide Cyclophosphamid... allogeneic hema... | - 60 Years | Masonic Cancer Center, University of Minnesota | |
| A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia | NCT05268003 | Acute Lymphobla... Leukemia | Ponatinib Venetoclax Mini-hyper CVD | 12 Years - | M.D. Anderson Cancer Center | |
| Safety and Efficacy Evaluation of Next-generation CD19-UCART | NCT05381181 | Acute Lymphobla... Non Hodgkin Lym... | CD19-UCART | 1 Year - 65 Years | Bioray Laboratories | |
| Intensified Post Remission Therapy Containing PEG-Asparaginase | NCT00184041 | Acute Lymphobla... | Daunorubicin, V... | 18 Years - 55 Years | University of Southern California | |
| Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy Individuals | NCT03581045 | Acute Lymphobla... | 18 Years - 39 Years | St. Jude Children's Research Hospital | ||
| Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia | NCT01025778 | Acute Lymphobla... Acute Myeloid L... | Clofarabine for... Etoposide for r... Cyclophosphamid... Clofarabine in ... Thiotepa in con... Melfalan in con... Haploidentical ... Donor lymphocyt... | 1 Year - 21 Years | Lund University Hospital | |
| Effect of Different Exercises on Quality of Life of Leukemia Patients. | NCT03147365 | Quality of Life Acute Lymphobla... Exercise | Aerobic exercis... Modified streng... | 8 Years - 12 Years | Children's Cancer Hospital Egypt 57357 | |
| Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies | NCT00270881 | Acute Myelogeno... Acute Lymphobla... Chronic Myeloge... Myelodysplastic... | Cord blood tran... TBI cyclophosphamid... cytarabine | 20 Years - 55 Years | Keio University | |
| CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant | NCT06059391 | Acute Lymphobla... Acute Myeloid L... Chronic Lymphoc... Chronic Myeloid... Hematopoietic a... Hodgkin Lymphom... Myelodysplastic... Myelofibrosis Myeloproliferat... Non-Hodgkin Lym... | Allogeneic Hema... Biospecimen Col... Granulocyte Col... Hematopoietic C... Multi-peptide C... Pheresis Placebo Adminis... Stem Cell Mobil... | 18 Years - | City of Hope Medical Center | |
| Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings | NCT04969601 | Acute Leukemia Acute Lymphobla... Acute Myeloid L... | vaccine COMIRNA... | 1 Year - 15 Years | Assistance Publique - Hôpitaux de Paris | |
| Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic Leukemia | NCT04767165 | Acute Leukemia | MRI | 6 Years - 18 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | |
| Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies | NCT00718757 | Non-Hodgkins Ly... Hodgkin's Disea... Acute Lymphobla... | Dexamethasone Irinotecan Vincristine | - 21 Years | St. Jude Children's Research Hospital | |
| ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 | NCT03286634 | Down Syndrome Acute Lymphobla... Childhood Cance... | Daunorubicin Prednisolone Vincristine Epirubicin E-coli L-aspara... 6-Mercaptopurin... Methotrexate Hydrocortisone Cytarabine Cyclophosphamid... | 0 Years - 20 Years | National Hospital Organization Nagoya Medical Center | |
| Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies | NCT03272633 | Acute Lymphobla... Acute Myeloid L... Hematopoietic C... JAK2 Gene Mutat... Loss of Chromos... Mantle Cell Lym... Minimal Residua... Myelodysplastic... Non-Hodgkin Lym... Plasma Cell Mye... RAS Family Gene... Recurrent Diffu... Recurrent Hemat... Recurrent Matur... Refractory Diff... Refractory Matu... Therapy-Related... Therapy-Related... TP53 Gene Mutat... | Allogeneic Hema... Irradiated Allo... | 18 Years - | Rutgers, The State University of New Jersey | |
| Nilotinib Pre and Post Allogeneic Stem Cell Transplantation | NCT00750659 | Chronic Myeloid... Acute Lymphobla... Stem Cell Trans... | Nilotinib | 18 Years - 65 Years | Sheba Medical Center | |
| CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies | NCT02529813 | Acute Biphenoty... Acute Lymphobla... Blasts 5 Percen... CD19 Positive Minimal Residua... Non-Hodgkin Lym... Small Lymphocyt... Stage III Chron... Stage IV Chroni... | Cyclophosphamid... Fludarabine Pho... Laboratory Biom... Tisagenlecleuce... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma | NCT03178617 | Acute Lymphobla... Acute Myeloid L... Lymphoblastic L... Acute Leukemia | Educational Int... Educational Int... Quality-of-Life... Questionnaire A... | 5 Years - | City of Hope Medical Center | |
| A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL | NCT02046694 | Acute Lymphobla... | Allopurinol | - 30 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years) | NCT01366898 | Acute Lymphobla... | Dexamethasona, ... | 55 Years - | PETHEMA Foundation | |
| Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 | NCT01044069 | Leukemia Acute Lymphobla... | gene-modified T... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Genomic Changes in Childhood Acute Lymphoblastic Leukemia | NCT01089907 | Acute Lymphobla... | 1 Day - 18 Years | National Taiwan University Hospital | ||
| Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer | NCT05400122 | Colorectal Canc... Hematologic Mal... Rectum Cancer Acute Myeloid L... Myelodysplastic... Acute Lymphobla... Chronic Myeloid... Chronic Lymphoc... Hodgkin Lymphom... Non Hodgkin Lym... Myeloproliferat... Plasma Cell Mye... | Vactosertib Fludarabine Pho... Cyclophosphamid... IL-2 Natural Killer ... | 18 Years - | Case Comprehensive Cancer Center | |
| AHN-12 Biodistribution in Advanced Leukemia | NCT01207076 | Acute Myelogeno... Myelodysplastic... Acute Lymphobla... Chronic Myeloge... | 90Y-AHN-12 | 12 Years - | Masonic Cancer Center, University of Minnesota | |
| A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia | NCT01196013 | Acute Lymphobla... | Clofarabine | 1 Year - 21 Years | Sanofi | |
| Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies | NCT03366350 | Acute Lymphobla... B Cell Lymphoma | Allogeneic hema... | - 70 Years | Wuhan Sian Medical Technology Co., Ltd | |
| Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia | NCT02336282 | Acute Lymphobla... | transcranial Di... Sham Cognitive Asses... Brain Games Sti... | 18 Years - | St. Jude Children's Research Hospital | |
| Infusion of Allogeneic, 3rd Party CD19-specific T Cells | NCT02274506 | Blood And Marro... Leukemia Lymphoma | Cyclophosphamid... Fludarabine T-Cell Infusion | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| Coagulopathy in Childhood Acute Lymphoblastic Leukaemia | NCT06242353 | Acute Lymphobla... Thrombosis Bleeding Hemostatic Diso... | Coagulopathy pa... | 1 Year - 17 Years | Karolinska University Hospital | |
| Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) | NCT00560794 | Acute Lymphobla... | Blinatumomab (M... | 18 Years - | Amgen Research (Munich) GmbH | |
| Dependence Receptors and Leukemia | NCT03278145 | Acute Lymphobla... Acute Leukemia | Genetic analyse... | 1 Year - 18 Years | Hospices Civils de Lyon | |
| A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL) | NCT01077544 | Chronic Myeloid... Acute Lymphobla... | Nilotinib | 1 Year - 17 Years | Novartis | |
| Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets | NCT01324336 | Acute Lymphobla... | 6-Mercaptopurin... | 4 Years - 17 Years | Children's Mercy Hospital Kansas City | |
| Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies | NCT01622556 | Hematologic Mal... | Fludarabine Busulfan Thymoglobulin Total Body Irra... Umbilical Cord ... | 18 Years - 70 Years | University of Virginia | |
| A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia | NCT04067518 | Acute Lymphobla... | SHP674 | 1 Year - 21 Years | Servier | |
| Treatment of Adult ALL With an MRD-directed Programme. | NCT00358072 | Acute Lymphobla... | Postremission c... | 15 Years - 65 Years | Northern Italy Leukemia Group | |
| Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | NCT03860844 | Acute Lymphobla... Acute Myeloid L... | Isatuximab Dexamethasone o... Fludarabine Cytarabine Liposomal dauno... Daunorubicin (n... Idarubicin Filgrastim or e... Mitoxantrone Doxorubicin Vincristine Pegaspargase (P... Cyclophosphamid... Etoposide Methotrexate L - Asparginase Hydroxyurea L - Asparaginas... | 28 Days - 17 Years | Sanofi | |
| Study of Sequential CAR-T Cell Treating Leukemia Children | NCT04340154 | Acute Lymphobla... Acute Lymphobla... Refractory Acut... | chimeric antige... | 0 Years - 18 Years | Beijing Boren Hospital | |
| Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia | NCT01457040 | Acute Lymphobla... Stem Cell Trans... | TBI+CY+VP-16 FA+TBI+CY+VP-16 | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy | NCT01643408 | Acute Lymphobla... Lymphoblastic L... | asparaginase Er... | 1 Year - 30 Years | Jazz Pharmaceuticals | |
| Cellular Therapy With Cord Blood Cells | NCT00427557 | Multiple Myelom... Leukemia Lymphoma | Fludarabine Melphalan Umbilical Cord ... Rituximab Peripheral Bloo... | - 80 Years | M.D. Anderson Cancer Center | |
| PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years | NCT01358201 | Acute Lymphobla... | vINCRISTINE Dexamethasone Methotrexate Cytosine arabin... | 55 Years - | PETHEMA Foundation | |
| RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL | NCT05127148 | Acute Lymphobla... | Evaluation of s... | 18 Years - 40 Years | Grupo Argentino de Tratamiento de la Leucemia Aguda | |
| Biology Studies of Hematologic Cancers | NCT00923442 | Acute Lymphobla... Myelodysplastic... Non-Hodgkins Ly... Acute Myelogeno... Hodgkins Lympho... | 1 Year - 75 Years | National Institutes of Health Clinical Center (CC) | ||
| Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT01142427 | Acute Lymphobla... | Cytology Specim... Laboratory Biom... | - 30 Years | Children's Oncology Group | |
| Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia | NCT02807883 | Acute Lymphobla... | Blinatumomab Hematopoietic C... | 1 Year - 70 Years | M.D. Anderson Cancer Center | |
| KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children | NCT02646839 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... | CliniMacs TCR a... | - 21 Years | Children's Hospital Los Angeles | |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
| Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL. | NCT02047578 | Acute Lymphobla... | Busulfan | - 21 Years | Seoul National University Hospital | |
| REALIB-LLA-2017: Idelalisib in Patients With Acute Lymphoblastic Leukemia | NCT03742323 | Acute Lymphobla... | Idelalisib | 18 Years - | PETHEMA Foundation | |
| Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer | NCT00005785 | Hematologic Neo... HIV Infection | GCSF Mobilized ... | - | National Institutes of Health Clinical Center (CC) | |
| Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | NCT02881086 | Acute Lymphobla... Lymphoblastic L... | Rituximab Nelarabine PEG-Asparaginas... Cranial irradia... Imatinib Idarubicin Dexamethasone Cyclophosphamid... Fludarabine Vincristine Mercaptopurine VP16 Daunorubicin (D... Methotrexate Stem cell trans... Cytarabine Vindesine Adriamycin Prednisolone | 18 Years - 55 Years | Goethe University | |
| Childhood Cancer Survivors' Affective Response to Exercise | NCT05763290 | ALL, Childhood Acute Lymphobla... | Affective Respo... | 18 Years - 39 Years | St. Jude Children's Research Hospital | |
| Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow | NCT00003838 | Myeloproliferat... Acute Myelogeno... Chronic Myeloge... Myelodysplastic... Acute Lymphobla... | T-cell replete ... Methotrexate Cyclosporine G-CSF | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT | NCT03810196 | Acute Leukemia Acute Myeloid L... Myelodysplastic... Acute Lymphobla... Mixed Lineage L... Lymphoblastic L... Burkitt Lymphom... Juvenile Myelom... | CliniMACS Cell ... | - 25 Years | Children's Hospital of Philadelphia | |
| A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia | NCT05268003 | Acute Lymphobla... Leukemia | Ponatinib Venetoclax Mini-hyper CVD | 12 Years - | M.D. Anderson Cancer Center | |
| Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase -An ALLTogether Pilot Study | NCT04843150 | Acute Lymphobla... | 1 Year - 45 Years | Aarhus University Hospital | ||
| SARS-CoV-2 Donor-Recipient Immunity Transfer | NCT04666025 | Accelerated Pha... Acute Lymphobla... Acute Myeloid L... Chronic Lymphoc... Chronic Phase C... COVID-19 Infect... Hematopoietic a... Hodgkin Lymphom... Lymphoblastic L... Myelodysplastic... Myelofibrosis Myeloproliferat... Non-Hodgkin Lym... | Biospecimen Col... Diagnostic Labo... Electronic Heal... Questionnaire A... | 18 Years - | City of Hope Medical Center | |
| Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study | NCT03733249 | Acute Lymphobla... Leukemia, Acute... Lymphoma, Non-H... Myelodysplastic... Primary Immunod... Anemia, Aplasti... Hemoglobinopath... Cytopenia Fanconi Anemia Diamond Blackfa... Thalassemia Anemia, Sickle ... | Rimiducid rivogenlecleuce... | 1 Month - 18 Years | Bellicum Pharmaceuticals | |
| Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases | NCT06013423 | Acute Leukemia ... Acute Lymphobla... Acute Myeloid L... Blastic Plasmac... Hematopoietic a... Mixed Phenotype... Myelodysplastic... Myeloproliferat... Non-Hodgkin Lym... Chronic Myeloid... | Biospecimen Col... Bone Marrow Asp... Cyclophosphamid... Cyclosporine Diagnostic Imag... Echocardiograph... Fludarabine Pho... Multigated Acqu... Mycophenolate M... Survey Administ... Thiotepa Total-Body Irra... Umbilical Cord ... | 6 Months - 65 Years | Fred Hutchinson Cancer Center | |
| Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies | NCT04008251 | Acute Lymphobla... B Cell Lymphoma | Second generati... | 14 Years - 70 Years | Wuhan Sian Medical Technology Co., Ltd | |
| Haplo Peripheral Blood Sct In GVHD Prevention | NCT04473911 | GVHD AML ALL MDS MPN CMML Hodgkin Lymphom... Non Hodgkin Lym... Blood Stem Cell... Graft Vs Host D... Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Myeloproliferat... Chronic Myelomo... Chemosensitive ... | FLUDARABINE CYCLOPHOSPHAMID... TBI Melphalan Sirolimus Mycophenolate m... RGI-2001 CYCLOPHOSPHAMID... | 18 Years - 80 Years | Massachusetts General Hospital | |
| Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab | NCT06125106 | Acute Lymphobla... | Blinatumomab | 18 Years - 70 Years | Zhejiang University | |
| Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 Protocol | NCT04825548 | Acute Lymphobla... Post Thrombotic... | No intervention | 1 Year - | Aarhus University Hospital | |
| Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | NCT00905398 | Precursor B-Cel... Acute Lymphobla... | Nilotinib | 18 Years - 75 Years | Universidade Federal do Rio de Janeiro | |
| Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies | NCT00038883 | Leukemia, Lymph... Leukemia, Lymph... Lymphoma, Low-G... Lymphoma, T-Cel... Lymphoma, B-Cel... | Campath-1H | 15 Years - 60 Years | M.D. Anderson Cancer Center | |
| Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia | NCT04770922 | Acute Lymphobla... Adverse Drug Ev... | - 21 Years | Cipherome, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
